CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 72 enrolled
Drug / intervention
Nano-Pulse Stimulation Devicedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03612570
NCT03612570N/ACompleted
CompareCT.gov

Evaluation of Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia

Pulse Biosciences, Inc.·interventional·Posted Aug 2, 2018·Updated Apr 12, 2024

In Brief

A clinical study evaluating Nano-Pulse Stimulation Device for Skin Lesion and 2 related conditions. Completed, enrolled 72 participants across 5 sites.

Detailed Summary

This prospective, open label, muti-center study evaluates the use of Nano-Pulse Stimulation (NPS) in the treatment of Sebaceous Hyperplasia (SH) lesions less than 2.5mm in size.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Lesion, Skin Abnormalities, Sebaceous Hyperplasia
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedAug 2, 2018
Enrollment StartJun 28, 2018
Primary CompletionSep 5, 2018
Study CompletionNov 28, 2018
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 7.9 years ago

Interventions

Nano-Pulse Stimulation Devicedevice

NPS utilizes a timed series of low energy, high voltage nanosecond (billionth of a second) pulses which are applied directly to targeted tissue using small microneedles. NPS energy induces cell signaling and the activation of cellular pathways by creating transient nanopores in cellular membranes and organelles and initiate regulated cell death.